Novartis completes acquisition of MorphoSys, plans squeeze-out and delisting

Novartis completed its acquisition of MorphoSys in May 2024, holding approximately 91.04% of shares as of June 20, 2024. Novartis plans to squeeze out minority shareholders and delist MorphoSys, offering EUR 68.00 per share.

“Novartis to Squeeze Out MorphoSys Minority Shareholders, Initiate Delisting”sparknewswire.com

• 1 source
• sparknewswire.comNovartis to Squeeze Out MorphoSys Minority Shareholders, Initiate Delisting - Spark NewswireBenzinga NewsdeskJun 20, 2024

Summarized from public sources; check the original articles before acting on it.